Signify® ER Drug Screen Test evaluation: Comparison to Triage® Drug of Abuse Panel plus tricyclic antidepressants

Clinica Chimica Acta

Volumn 328, Issue 1-2, 2003, Pages 31-38

  Phillips, Jane Ellen ^a   Bogema, Stuart ^b   Fu, Paul ^c   Furmaga, Wieslaw ^d   Wu, Alan H B ^d   Zic, Vlasta ^c   Hammett Stabler, Catherine ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b Forensic Testing Inc   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d HARTFORD HOSPITAL   (United States)

Author keywords

Drug screen; Drugs of abuse; Emergency medicine diagnostics; Immunoassay; Point of care testing

Indexed keywords

AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; METHAMPHETAMINE; OPIATE; PHENCYCLIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; STREET DRUG;

ACCURACY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DEVICE; DRUG SCREENING; EMERGENCY HEALTH SERVICE; EVALUATION; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; URINALYSIS; URINE; COMPARATIVE STUDY; METHODOLOGY;

CANNABIS SATIVA;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; HUMANS; IMMUNOASSAY; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 0037304873     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00240-1     Document Type: Article

References (10)

1. Hammett-Stabler C., Pesce A.J., Cannon D.J. Urine drug screening in the medical setting. Clin. Chim. Acta. 315:2002;125-135.
2. Braithwaite R.A., Jarvie D.R., Minty P.S., Simpson D., Widdop B. Screening for drugs of abuse. I: opiates, amphetamines, cocaine. Ann. Clin. Biochem. 32(Pt. 2):1995;123-153.
3. Wu A.H.B., Wong S.S., Johnson K.G.et al. Evaluation of the Triage system for emergency drugs-of-abuse testing in urine. J. Anal. Toxicol. 17:1993;241-245.
4. United Chemical Technologies SPE Applications Manual, 1999, Therapeutic and abused drugs in urine, p. 6.
5. Wu AHB, Broussard L, Hoffman RS, Kwong TC, McKay C, Moyer TP, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines Recommendations for the Use of Laboratory Tests to Support the Impaired and Overdosed Patient from the Emergency Department. Draft, March 25, 2002.
6. Montague R.E., Grace R.F., Lewis J.H., Shenfield G.M. Urine drug screens in overdose patients do not contribute to immediate clinical management. Ther. Drug Monit. 23:2001;47-50.
7. Skelton H., Dann L.M., Ong R.T.T., Hamilton T., Ilett K. Drug screening of patients who deliberately harm themselves admitted to the emergency department. Ther. Drug Monit. 20:1998;98-103.
8. Kadehjian L.J. Performance of five non-instrumented urine drug-testing devices with challenging near-cutoff specimens. J. Anal. Toxicol. 25(8):2001;670-679.
9. Ferrara S.D., Tedeschi L., Frison G.et al. Drugs of abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques. J. Anal. Toxicol. 18:1994;278-291.
10. Wenning R., Moeller M.R., Haguenoer J.M.et al. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine. J. Anal. Toxicol. 22(2):1998;148-155.